Shop By
Catalog No.
Product Name
Application
Product Information
Product Citation
-
Factor Xa inhibitor
Apixaban is an anticoagulant for the prevention of venous thromboembolism and venous thromboembolic events.- Daniël Verhoef, .et al. , Nat Commun, 2017, 8: 528 PMID: 28904343
-
Factor Xa inhibitor
Rivaroxaban is an oxazolidinone derivative optimized for inhibiting both free Factor Xa and Factor Xa bound in the prothrombinase complex.- Stefan Bittmann, .et al. , J Regen Biol Med, 2020, 2(2):1-3
- Daniël Verhoef, .et al. , Nat Commun, 2017, 8: 528 PMID: 28904343
- Mizuki Yamamoto, .et al. , Antimicrob Agents Chemother, 2016, Nov; 60(11): 6532-6539 PMID: 27550352
-
FXa Inhibitor
Betrixaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It is potent, orally active and highly selective for factor Xa, being selected from a group of similar compounds for its low hERG affinity. -
Factor Xa inhibitor
Edoxaban is a selective factor Xa inhibitor with Ki of 0.561 nM- Daniël Verhoef, .et al. , Nat Commun, 2017, 8: 528 PMID: 28904343
-
Factor Xa inhibitor
5-R-Rivaroxaban is (R) enantiomer of Rivaroxaban. Rivaroxaban is a novel, oral, direct Factor Xa (FXa) inhibitor in late-stage development for the prevention and treatment of thromboembolic disorders. -
Factor Xa inhibitor
Edoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention. -
factor Xa inhibitor
Fondaparinux sodium is a factor Xa inhibitor to form the high affinity binding site for the anti-coagulant factor antithrombin III (ATIII).
